TABLE 4

Multivariable Analysis of Clinical Indicators and Marrow Status by PET/BMB on Survival

	OS		EFS
Variable	HR	P	HR	P
Age > 60 y	1.51 (0.82–2.77)	0.18	0.96 (0.60–1.54)	0.86
Ann Arbor stage III/IV	1.16 (0.54–2.50)	0.70	1.21 (0.70–2.08)	0.50
>1 extranodal site	1.27 (0.66–2.46)	0.47	1.20 (0.73–1.96)	0.47
LDH level > normal	2.42 (1.26–4.67)	0.01	2.22 (1.39–3.56)	<0.01
Eastern Cooperative Oncology Group performance status ≥ 2	1.55 (0.79–3.05)	0.21	1.56 (0.93–2.64)	0.10
PET–/BMB+	0.49 (0.07–3.68)	0.49	1.13 (0.40–3.20)	0.83
PET+/BMB–	0.74 (0.33–1.66)	0.46	0.68 (0.37–1.27)	0.23
PET+/BMB+	2.26 (1.02–5.03)	0.05	1.61 (0.84–3.10)	0.15